Chromobacterium violaceum: A review of pharmacological and industiral perspectives

Critical Reviews in Microbiology

Volumn 27, Issue 3, 2001, Pages 201-222

  Durán, Nelson ^a,b   Menck, Carlos F M ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

3,6 DIHYDROXY 1,2 BENZISOXAZOLE; ANTIINFECTIVE AGENT; ARPHAMENINE A; ARPHAMENINE B; FR 901228; PIGMENT; UNCLASSIFIED DRUG; VIOLACEIN; YTO 678 H;

BACTERIAL GENETICS; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BIOSYNTHESIS; CHROMOBACTERIUM; CHROMOBACTERIUM VIOLACEUM; CLASSIFICATION; HUMAN; METABOLITE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REVIEW;

EID: 0034805976     PISSN: 1040841X     EISSN: None     Source Type: Journal    
DOI: 10.1080/20014091096747     Document Type: Review

References (186)

1. Comparison of the in vitro of citoprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobacterium violaceum
2. Isolement dun Chromobacterium violaceum a partir de lessions hepatiques observees chez un singe Cercopithecus cephus etude et pouvoir pathogene
3. Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum
4. Hydroxylases VioABCD in Chromobacterium violaceum
5. Quorum sensing autoinducers: Do they play a role in natural microbial habitats?
6. The synthesis of violacein and related compounds
7. The chemistry of bacteria. Part VIII. The synthesis of violacein and related compounds
8. Denitrification by Chromobacterium violaceum
9. Copper in biological system. A report from 6th. Manziana Conference
10. Um nuevo bacterio colorato
11. Septicemia and death caused by Chromobacterium violaceum
12. Recurrent nonfatal Chromobacterium violaceum infection in a nonimmunocompromised patient
13. Extraction of violacein from Chromobacterium violaceum provides a new quantitative bioassay for N-acyl homoserine lactone autoinducers
14. Matière colorante se formant dans la colle de farine
15. Studies in the nomenclature and classification of the bacteria
16. Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells
17. Novel therapies for chronic lymphocytic leukemia in the 21st century
18. Photochemistry and photobiology in a virgin land
19. Um pigmento nas águas negras
20. Preliminary experiments on the photobiological properties of violacein
21. Acute pleuropneumonia in Barbary sheep (Amnotragus lervia) asociated with Chromobacterium violaceum
22. Production of acyl-homoserine lactone quorum-sensing signals by Gram-negative plant-associated bacteria
23. Case report and review of Chromobacterium sepsis-a Gram negative sepsis mimicking melioidosis
24. Crystallization and preliminary X-ray analysis of IND, an enzyme with indole oxygenase activity from Chromobacterium violaceum
25. Phenylalanine hydroxylase from Chromobacterium violaceum. Uncoupled oxidation of tetrahydropterin and the role of iron in hydroxylation
26. Chitinolytic activity in Chromobacterium violaceum: Substrate analysis and regulation by quorum sensing
27. Promising new agents under development by the division of cancer treatment, diagnosis, and centers of the National Cancer Institute
28. Chromobacterium violaceum infection in a stumptailed monkey (Macaca artoices)
29. Novel potentiators of β-lactam antibiotics. Isolation of SQ28,504 and SQ28,546 from Chromobacterium violaceum
30. Violacein/cyclodextrin inclusion complex by diffusion coefficient and circular dichroism measurements
31. Biological activities of new antitumoral of indole derivatives in a inclusion complex with cyclodextrin
32. Antioxidant activity of an inclusion complex of violacein and β-cyclodextrin
33. Antiulcerogenic activity of violacein/cyclodextrin inclusion complexes and violacein
34. Violacein
35. Physiological aspects of violacein biosynthesis in nonproliferating cells
36. 14-labeled substrates into violacein
37. Atividade da violaceina in vitro sobre o Mycobacterium tuberculosis H37RA
38. Chromobacterium, Eikenella, Kingella, Neisseria, Simonsiella, and Vitreoscilla species comprise a major branch of the beta group proteobacteria by 16S ribosomal ribonucleic acid sequence comparison: Transfer of Eikenella and Simonsiella to the family Neisseriaceae (emend.)
39. Chromobacterium violaceum 16S ribosomal RNA, complete cds
40. Violaceina: A descoberta de um antibiótico
41. Biosynthesis of trypanocide by Chromobacterium violaceum
42. Violacein transformation by peroxidase and oxidases: Implications on its biological properties
43. Bacterial chemistry-II: Antimicrobial photoproduct from pigment of Chromobacterium violaceum
44. Bacterial chemistry. III. Preliminary studies on trypanosomal activities of Chromobacterium violaceum products
45. Bacterial chemistry-I: Studies of a potential phototherpaeutic substance from Chromobacterium violaceum
46. Trypanocide. State of art
47. Nuevo metodo de sintesis de N-indol-glicosideos com actividad antimicrobiana
48. Violacein in an investigational AIDS-related lymphoma screen in vitro
49. In vitro evaluation of violacein on AIDS-related lymphoma and human tumor cells lines
50. Chemistry, biochemistry and clinical aspects of a microbiological new compounds
51. β-lactamase activity in Chromobacterium violaceum
52. Chromobacterium violaceum infection: Report of a fatal case
53. Chromobacterium violaceum infection of the eye: A report of 2 cases
54. Phenylalanine 4-monooxygenase from Chromobacterium violaceum
55. Infection by Chromobacterium violaceum in a patient with acquire immunodeficiency virus infection
56. L-Tryptophan 2′,3′-oxidase from Chromobacterium violaceum
57. Near-fatal septicemia with Chromobacterium violaceum
58. The genera Chromobacterium and Janthinobacterium
59. Chromobacterium violaceum septicemia in a dog
60. Valorization of maize bran to obtain biodegradable plastic films
61. Natural infections of Gibbons with s bacterium producing violet pigment (Chromobacterium violaceum)
62. A new antibiotic, 3,6-dihydroxyundoxazene
63. Asymmetric deuteration of N-acetyl-(Z)-α, β-dehydrotryptophan-(L)-phenylalanine methyl ester produced by (L)-tryptophan 2′,3′-oxidase from Chromobacterium violaceum. A new route for stereospecific labelling of peptides
64. Fatal Chromobacterium violaceum septicemia
65. Chromobacterium violaceum 16S and 23S rRNA gene
66. Bacterial chemistry. VI. Biological activities and cytotoxicity of 1,3-dihydro-2H-indol-2-one derivatives
67. Antitumoric antibiotic WB968 manufacture with Chromobacterium
68. Chromobacterium violaceum sepsis accompanied by bacteria-associated hemophagocytic syndrome in a Japanese man
69. Chromobacterium violaceum-violacein biosynthetic gene cluster (VioABCD)
70. Biosynthesis of violacein: A novel rearrangement in tryptophan metabolism with a 1,2-shift of the indole ring
71. Biosynthesis of violacein: Origins of hydrogen, nitrogen and oxygen atoms in the 2-pyrrolidone nucleous
72. A new metabolite of tryptophan, chromopyrrolic acid, produced by Chromobacterium violaceum
73. Biosynthesis of violacein. 1. Oxygenation at the 2-position of the indole ring and structures of proviolacein, prodeoxyviolacein and pseudoviolacein, the plausible biosynthetic intermediates of violacein and deoxyviolacein
74. Biosynthesis of violacein: Evidence for the intermediacy of 5-hydroxy-L-tryptophan and structure of a new pigment, oxyviolacein, produced by the metabolism of 5-hydroxytryptophan
75. Pseudodeoxyviolacein, a new red pigment produced by tryptophan metabolism of Chromobacterium violaceum
76. Chromobacterium violaceum in tropical northern Australia
77. Microbes with polyhydroxyalkanoates (PHA) biosyntheis genes integrated into their chromosome and method for producing PHAs and screening for PHA genes
78. Fatal Chromobacterium violaceum septicemia
79. First case report from Argentina of fatal septicemia caused by Chromobacterium violaceum
80. Chemical modification of extracellular cytosine deaminase from Chromobacterium violaceum YK 391
81. Recovering gold from gold ore or carbonaceous gold, using microorganisms which produce cyanide ion or which degrade cyanide ion
82. Cloning, molecular analysis, and expression of the polyhydroxyalkanoic acid synthase (phaC) gene from Chromobacterium violaceum
83. Chromobacterium violaceum SoxR homolog gene, complete cds
84. Chromobacterium violaceum polyhydroxyalkanoate synthase (phaC) gene, complete cds; 3-ketothiolase (phaA) gene, partial cds; and unknown gene
85. Chromobacteriosis (Chromobacterium violaceum) in a 3 colobus monkeys (Colobus polykomos)
86. Chromobacterium violaceum, an unusual pathogen of swine
87. Spectroscopic properties of violacein and related compound: Crystal structure of tetramethylviolacein
88. Gold solubilization by the cyanide producing bacteria Chromobacterium violaceum
89. Two cases of Chromobacterium violaceum infection after injury in a subtropical region
90. Tryptophan hydroxylase of Chromobacterium violaceum
91. Total synthesis of the antitumor depsipeptide FR-901,228
92. Violacein an antibiotic pigment produced by Chromobacterium violaceum
93. An acute pleuropneumpnia in a pig caused by Chromobacterium violaceum
94. Purification and properties of β-cyano-L-alanine synthase from the cyanide producing bacterium Chromobacterium violaceum
95. Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern
96. Chromobacterium violaceum infectious and chronic granulomatous disease
97. Infección por Chromobacterium violaceum. Presentación de un caso com evolución fatal
98. Chromobacterium violaceum septicemia- The intensive care management of 2 cases
99. Purification of the antiviral compound violacein from cultures of Chromobacterium
100. In vitro evaluation of violacein toxicity in different cell lines
101. Violacein cytotoxicity and induction of apoptosis in V79 cells
102. Isolation and identification of poly(3-hydroxyvalerate)-degrading strains of Pseudomonas lemoignei
103. Quorum sensing and Chromobacterium violaceum: Exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones
104. Chromobacterium violaceum infection in a nonhuman primate (Macaca assamensis)
105. Chromobacterium violaceum infection
106. A comparative study of virulent and avirulent strains of Chromobacterium violaceum
107. Biosynthesis of violacein: Intact incorporation of the tryptophan molecule on the oxindole side, with intramolecular rearrangement of the indole ring on the 5-hydroxyindole side
108. Studies on the biosynthesis of violacein. Part 9. Green pigments possessing tetraindole and dipyrromethene moieties, chromoviridans and deoxychromoviridans, produced by a cell-free extract of Chromobacterium violaceum and their biosynthetic origins
109. Metabolic products of microroganisms LXV. Ferrioxamines for Eubacteriales
110. Apoptotic cytotoxic effects of a histone deacetylase inhibitors, FK228, on malignant lymphoid cells
111. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
112. Phenylalanine hydroxylase from Chromobacterium violaceum, purification and characterization
113. Fatal infection due to Chromobacterium violaceum in Vietnam
114. Isolation of two intermediates of arphamenine B biosynthesis
115. Human infection due to Chromobacterium violaceum. A report from Ilorin, Nigeria
116. Cloning and expression of Chromobacterium violaceum phenylalanine hydroxylase in Escherichia coli and comparison of amino acid sequence with mammalian aromatic amino acid hydroxylases
117. Chromobacterium violaceum phenylalanine hydroxylase gene, complete cds
118. Aerocyanidin, a new antibiotic produced by Chromobacterium violaceun
119. Mechanistic studies on phenylalanine hydroxylase from Chromobacterium vlaceum. Evidence for the formation of an enzyme-oxygen complex
120. Chromobacterium violaceum phenylalanine 4-monooxygenase
121. Cloning and heterologous expression of the violacein biosynthesis gene cluster from Chromobacterium violaceum
122. Recurrent infection with Chromobacterium violaceum: First case report from South America
123. Fatal Chromobacterium violaceum infections associated with exposure to stagnant water
124. CXL. On the pigment produced by Chromobacterium violaceum
125. Purification and characterization from Chromobacterium violaceum of an enzyme catalyzing synthesis of γ-cyanoα-aminobutyric acid and thiocyanate
126. Production, extraction and purification of violacein: An antibiotic produced by Chromobacterium violaceum
127. Chromobacterium violaceum, opportunistic pathogenic bacteria isolated in tropical and subtropical areas
128. Chromobacterium violaceum, opportunistic pathogenic bacteria isolated in tropical and subtropical areas
129. Bacterial chemistry-IV: Total characterization of violacein. An antibiotic trypanocide from Chromobacterium violaceum
130. Bacterial chemistry-V: Effect of growth conditions on production of violascein by Chromobacterium violaceum BB-78 strain
131. Chromobacterium violaceum infection of the deep neck tissues in a traveler to Thailand
132. P21-dependent G(1) arrest with downregulation of cyclin D1 and upregulation od cyclin E by the histone deacetylase inhibitor FR901228
133. FR901228 causes mitotic arrest but does not alter microtubule polymerization
134. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum N°-968.2. Structure determination
135. Isolation of bacteria producing bluish-purple pigment and use for dyeing
136. Serine hydroxymethyltransferase and glycine cleavage enzyme from the cyanogenic bacterium Chromobacterium violaceum
137. Bacterial plastic comes to market
138. Chromobacterium violaceum as a cause of periorbital cellulitis
139. Aerocavin, a new antibiotic produced by Chromobacterium violaceum
140. Outbreaks of disease in animals associated with Chromobacterium violaceum. 1. The disease in swine
141. Pathogenicity of nonpigmented cultures of Chromobacterium violaceum
142. Solubilization of gold by Chromobacterium violaceum
143. Fatal infection by Chromobacterium violaceum
144. Chromobacrterium violaceum, pathogenic for man
145. Chromobacterium violaceum adenitis acquired in the northern United States as complication if chronic granulomatous disease
146. Chromobacterium violaceum presenting as a surgical emergency
147. Synthesis and production of poly(3-hydroxyvaleric acid) homopolyester by Chromobacterium violaceum
148. Large-scale production of poly (3-hydrovaleric acid) by fermentation of Chromobacterium violaceum, processing, and characterization of the homopolyester
149. Nonfatal and fatal infections caused by Chromobacterium violaceum
150. The pigment of Bacillus violaceus I. The production, extraction, and purification of violacein
151. Osteomyelitis associated with Chromobacterium violaceum sepsis-case-report
152. Chromobacterium violaceum 16S ribosomal RNA gene, partial sequence spanning the V3-V4 regions
153. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum N°968. 1. Taxonomy, fermentation, isolation, physicochemical and biological properties, and antitumor activity
154. Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum N°968, on Ha-Ras transformed NIH3T3 cells
155. The structure of the O-specific polysaccharide of the lipopolysaccharide from Chromobacterium violaceum NCT9694
156. Chromobacterium violaceum phenylalanine hydroxylase: Cloning, purification, and iron-dependent catalysis
157. Chromobacterium violaceum phenylhydroxylase gene, complete cds
158. SQ 26,180, a novel monobactam. I. Taxonomy, fermentation and biological properties
159. Chromobacterium violaceum infection in pigs
160. A probable case of Chromobacterium violaceum infection in Australia
161. Bacillus violaceus manilae (a pathogenic organism)
162. Purification and properties of extracellular cytosine deaminase from Chromobacterium violaceum YK 391
163. Review of Bergonzini on Cromobacterium